2024
FFBW Ffbw Inc
CIB Bancolombia SA
TARA Protara Therapeutics Inc
SLAMU Slam Corp
SY So-Young International Inc
BHR Braemar Hotels & Resorts Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value

NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.

Closing Price: $3.64

Day's Change: -0.04 (-1.09%)

Bid: --

Ask: --

B/A Size: --

Day's High: 3.67

Day's Low: 3.45

Volume (Light) Volume: 23,881 10-day average volume: 71,663: 23,881

Freeport-McMoRan Inc. Stock Rises Wednesday, Still Underperforms Market

4:53 pm ET May 4, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Freeport-McMoRan Inc. (FCX) rose 2.86% to $41.30 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 2.99% to 4,300.17 and the Dow Jones Industrial Average rising 2.81% to 34,061.06. The stock's rise snapped a three-day losing streak. Freeport-McMoRan Inc. closed $10.69 below its 52-week high ($51.99), which the company achieved on March 25th.

Trading volume (17.6 M) remained 381,768 below its 50-day average volume of 18.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

May 04, 2022 16:53 ET (20:53 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and